Lesinurad (trade name Zurampic) is a urate transporter (URAT1) inhibitor for treating hyperuricemia associated with gout. It received FDA approval on 22 December 2015. Lesinurad has been approved by the U.S Food and Drug Administration on 22 December 2015.
Product Name: Lesinurad
CAS Number: 878672-00-5
Molecular Weight:  404.2805
Molecular Formula:  C17H14BrN3O2S
Purity (HPLC): ≥99%
Shipping Conditions: Room temperature.
Storage Conditions: Refrigerated.
Regulatory Statement:  For Research Use Only.